Fidaxomicin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with fidaxomicin
E
- E S P (erythromycin / sulfisoxazole)
- E-Mycin (erythromycin)
- E.E.S. Granules (erythromycin)
- E.E.S.-200 (erythromycin)
- E.E.S.-400 (erythromycin)
- E.E.S.-400 Filmtab (erythromycin)
- efavirenz / emtricitabine / tenofovir
- efavirenz / lamivudine / tenofovir
- elacestrant
- elagolix
- elagolix / estradiol / norethindrone
- elexacaftor / ivacaftor / tezacaftor
- eliglustat
- ella (ulipristal)
- Embeda (morphine / naltrexone)
- Emblon (tamoxifen)
- emtricitabine / lopinavir / ritonavir / tenofovir
- emtricitabine / nelfinavir / tenofovir
- emtricitabine / rilpivirine / tenofovir
- emtricitabine / rilpivirine / tenofovir alafenamide
- emtricitabine / tenofovir
- emtricitabine / tenofovir alafenamide
- encorafenib
- Endometrin (progesterone)
- Entereg (alvimopan)
- Envarsus XR (tacrolimus)
- enzalutamide
- Epclusa (sofosbuvir / velpatasvir)
- erdafitinib
- Erleada (apalutamide)
- Ery-Tab (erythromycin)
- Eryc (erythromycin)
- EryPed (erythromycin)
- Erythrocin (erythromycin)
- Erythrocin Lactobionate (erythromycin)
- Erythrocin Stearate Filmtab (erythromycin)
- Erythrocot (erythromycin)
- erythromycin
- erythromycin / sulfisoxazole
- Eryzole (erythromycin / sulfisoxazole)
- estradiol / norethindrone / relugolix
- estradiol / progesterone
- everolimus
- Evivo (bifidobacterium infantis)
- Evivo With MCT Oil (bifidobacterium infantis)
More about fidaxomicin
- fidaxomicin consumer information
- Check interactions
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: macrolides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.